SpyGlass Pharma buys Santen unit Advanced Vision Science for about $13 million cash
Bitget2026/10/01 12:04- SpyGlass Pharma bought Advanced Vision Science from Santen for about USD 13 million in cash, taking 100% of the shares.
- The deal secures commercial-scale manufacturing capacity for intraocular lenses used in the Phase 3 BIM-IOL System trials.
- AVS will remain the exclusive supplier of several IOL types to Santen for commercialization in Japan.
- Ongoing licensing includes AVS’s hydrophobic acrylic lens material for Bausch + Lomb’s enVista IOL line.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Report: SK Hynix abandons Solidigm US IPO plan
Solidigm originated from SK Hynix’s acquisition of Intel’s NAND flash and SSD business. Lee Chan-jin, Chairman of Korea’s Financial Supervisory Service, stated that Solidigm’s listing in the U.S. could be subject to Korea’s duplicate listing regulations. Previous reports indicated that Solidigm is considering going public on Nasdaq as early as 2027, with a potential valuation of up to 150 billions of dollars.
Elon Musk accelerates the creation of the "fourth largest U.S. carrier"! SpaceX (SPCX.US) plans to acquire 80,000 cellular base stations, offering new opportunities for communication tower companies
According to sources familiar with the matter, SpaceX plans to acquire at least 80,000 cellular base station sites in the United States and is currently in negotiations with at least one major cellular infrastructure company to achieve this goal.
Crypto prices
More
